Multi-Cancer Early Detection (MCED) tests offer enhanced capabilities for earlydiagnosis and monitoring. Screening for specific cancers like lung, cervical, colorectal, and prostate is evolving with advanced imaging…
precision oncology through somatic and germline variant analysis, alongside liquidbiopsies for non-invasive cancer monitoring. The role of pharmacogenomics in personalizing drug therapies and functional genomicsin…
Artificial \textit{Intelligence} (AI) is transforming lung cancer diagnosis and prognosis, enhancing accuracy through the fusionof image and clinical data. Significant advancements in AI technologies show promise for…
dynamic insights into tumor biology, enabling early detection, precise treatment monitoring, and identification ofminimal residual disease. Across various cancer types, ctDNA guides therapeutic decisions, predicts…
gastric cancers. Key biomarkers such as circulating tumorDNA, microRNAs, exosomes, and circulating tumor cells are highlighted for their potential in early detection, prognosis, and treatment monitoring. The collective…
applications. Key themes include the detection of pathogenic bacteria, cancer biomarkers, and environmental pollutants, alongside advancements in therapeutic drug monitoring and protein detection. Different biosensing…
modalities are transforming various fields, offering non-invasive molecular insights. Key applications include cancer diagnosis, therapeutic monitoring, environmental pollution detection, and food quality assessment…
cancer staging. Advances in acquisition, analysis, and AI integration are enhancing its capabilities, while challenges in standardization and interpretation are being addressed. The technique is also vital for…
Precision approaches leverage liquid biopsies and circulating tumor DNA for real-time monitoring and early detection [4, 7], alongside targeting DNA damage response pathways [2]. The integration of multi-omics…
other biomarkers in bodily fluids, presents a less invasive approach for ovarian cancer diagnosis, monitoring, and treatment selection. It aids in early detection, identifying minimal residual disease (MRD), and guiding
Bladder cancer (BC) is a major global health challenge, with early detection and monitoring heavily reliant on invasive cystoscopy due to the shortcomings of existing point-of-care (POC) diagnostic
across species. Animals, therefore, serve as valuable models for studying human diseases such as cancer, cardiovascular disorders, diabetes, and infectious diseases. For example, rodents are commonly used to investigate…
epigenetic biomarkers [10] are identifying novel indicators for sarcomas and other cancers. \textit{MinimalResidual Disease} (MRD) monitoring [6], alongside traditional immunohistochemistry [9], refines treatment…
regions with intense UV radiation. The session begins with an overview of skin cancer epidemiology and risk stratification, emphasizing the growing burden in both high-income and low-resource settings…
Targeted therapies are transforming endometrial cancer treatment by addressing specific molecular alterations. This includes inhibitors targeting PI3K/AKT/mTOR, HER2, and DNA damage repair pathways, showing promise for…
Endometrial cancer treatment is advancing with targeted therapies and immunotherapies addressing resistance. Key strategies involve targeting PI3K, HER2, and DNA mismatch repair deficiencies. Pembrolizumab demonstrates…
Ovarian cancer chemotherapy, primarily platinum-based and taxane regimens, leads to significant toxicities including gastrointestinal, hematological, and neurological issues. Peripheral neuropathy, myelosuppression…
covers advancements in neurodegenerative disease diagnosis, oncology treatment response prediction, acute stroke management, prostate cancer characterization, and cardiac fibrosis assessment. The utility of quantitative…
biomarkers in contemporary healthcare. It details their application in diagnosing, prognosing, and monitoring diverse conditions, including cancer, chronic diseases, infections, autoimmune disorders, and…
Biomarkers are very instrumental in monitoring treatment response to therapies in cancer care. Biomarker concentration measurements at the beginning of and during treatment enabled assessment of therapeutic efficacies…
treatment, primarily in delivering chemotherapy drugs and supporting overall health. Blood tests monitor treatment effectiveness, track cancer markers, and assess organ function. Additionally, blood transfusions may be…
Colorectal cancer research is rapidly advancing across multiple fronts. Studies address the rising incidence of early-onset disease, advocating for updated screening guidelines. Personalized medicine, immune checkpoint…
For authors and organisers
Publish, present and keep up with your field
Find the right journal for your paper and submit your manuscript.